ManageArtworks paid ads audit: 98 LinkedIn ads, two landing templates, and a clear message-match opportunity
ManageArtworks runs a disciplined LinkedIn campaign aimed at pharma labeling and CPG packaging buyers. The ad creative is unusually specific: regulatory deadlines, 21 CFR Part 11 compliance, AI font and barcode checks, and 25+ language packaging accuracy. The landing pages mostly route to two solution templates (pharma and CPG packaging), and both lead with broader workflow framing that softens the sharp promises each ad sold. The result is a B/C band across five destinations and a clear playbook for closing the gap.
Snapshot
- Total ads found
- 98
- Channels
- Scored destinations
- 5
- Average score
- 6.7 (C+)
- Campaign theme
- Pharma labeling and CPG packaging artwork management
How this account runs paid ads
ManageArtworks is the rare B2B advertiser whose creative is sharper than its landing pages. The LinkedIn ad library shows 98 active variants split between two buyer segments: pharma labeling teams (three destinations under /solutions/pharma-artwork-management) and CPG packaging teams (two destinations under /solutions/cpg-packaging-artwork-management). Each ad cluster opens with a specific technical hook: 21 CFR Part 11 audit trails, AI-powered proofing for font and barcode checks, multilingual accuracy across 25+ languages, or PDP sizing and font analysis.
The landing strategy is template-based. All three pharma destinations route to the same /solutions/pharma-artwork-management page (with different LinkedIn tracking parameters), and both CPG destinations route to the same /solutions/cpg-packaging-artwork-management page. That is an efficient setup, but it forces one hero to do the job of multiple ad clusters. The page leads with a generic 'Streamline your Pharma Labeling Process' or 'Centralize Artwork Management for multiple SKUs' headline that does not echo any of the ads' specific hooks.
The pharma side fares better than the CPG side. Pharma destinations score 6.7 to 7.7 because the broader page content (workflow modules, compliance language, audit trail callouts) backs up the implicit promise. The CPG side dips to 5.7 because the multilingual and PDP proofing capabilities are buried, leaving the most ad-specific clicks the least supported.
Page report card
AI proofing ad lands on a page that covers the workflow but leads with a generic labeling-process headline instead of the proofing hook.
Best-scoring pharma destination. The deadline-and-approval ad lands on a page that fully delivers the underlying workflow story.
21 CFR Part 11 ad lands on a page that buries the compliance promise behind a generic workflow hero.
25+ language multilingual ad lands on a CPG page that only mentions multilingual support deep in the body copy.
PDP-sizing and font-check ad lands on the same CPG template that leads with SKU centralization rather than the specific proofing tools.
This table only shows pages with a reviewed ad sample and a published score.
Common patterns
// Pattern 01
Specific ad hooks land on broad page heroes
Every captured ad opens with a specific technical promise (21 CFR Part 11, AI font checks, 25+ languages, PDP sizing). The landing hero on both solution pages is a broader workflow line. Echoing the dominant ad hook in the H1 is the highest-leverage rewrite across the account.
// Pattern 02
Two templates absorb five distinct ad clusters
The pharma template serves three different ad-group destinations and the CPG template serves two. That is fine for downstream content but expensive at the headline. Dynamic hero variants by referrer (or per-ad-group landing pages) would let each cluster see the exact promise it clicked on.
// Pattern 03
Pharma page is the credibility anchor
Audit-trail callouts, regulatory dates, and workflow modules already exist deeper on the pharma page. Surfacing them above the fold would turn the page from generic into proof-led without rewriting the offer.
// Pattern 04
CPG page is the weakest link
The two lowest-scoring destinations both route to the CPG packaging template. Multilingual support and PDP proofing are real product capabilities, but they appear after several scrolls. That gap drags the CPG-side average below the pharma side.
Should you copy this playbook?
If you sell into regulated industries with multiple buyer segments, ManageArtworks' creative approach is worth copying. Their LinkedIn ads are concrete, segment-specific, and built on real product capabilities (compliance, multilingual support, AI proofing). That kind of specificity is what beats generic 'streamline your workflow' inventory on LinkedIn.
What you should not copy is using one solution template per buyer segment to absorb several different ad clusters. The cheap upgrade is dynamic heroes by ad group, or per-cluster landing pages that echo the dominant ad H1 verbatim. That single change would likely move two pages from C to B and one page from B to A without changing the offer or the spend.
Sources
- LinkedIn Ad Library: Ad samples and creative copy captured from public LinkedIn Ad Library listings
- ManageArtworks landing pages: Live captures of the pharma and CPG packaging solution pages
Want the same teardown for your account?
ManageArtworks' audit covered 98 LinkedIn ads across five destinations. We can do the same teardown for your account, score each landing page against its dominant ad cluster, and hand you the H1 rewrites that close the message-match gap.
Audit my full account